Current Report Filing (8-k)
January 17 2017 - 4:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 12,
2017
CHINA HEALTH INDUSTRIES HOLDINGS,
INC.
(Exact name of Company as specified in
charter)
Delaware
|
000-51060
|
86-0827216
|
(State or other jurisdiction
|
(Commission File No.)
|
(IRS Employer
|
of Incorporation)
|
|
Identification No.)
|
168 Binbei Street, Songbei District, Harbin City
Heilongjiang Province, Peoples Republic of China 150028
|
(Address of principal executive offices) (Zip Code)
|
Companys telephone number, including area code:
86-451-88100688
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the Company under
any of the following provisions:
[ ] Written communications pursuant to Rule 425
under the Securities Act (17CFR230.425)
[ ] Soliciting material pursuant to Rule14a-12
under the Exchange Act (17CFR240.14a -12)
[ ] Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17CFR240.14d -2(b))
[ ] Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17CFR240.13e -4(c))
Item 4.01.
|
Changes in Registrants Certifying
Accountant.
|
On January 12, 2017, China Health Industries Holdings, Inc., a
corporation incorporated under the laws of the State of Delaware (the
Company
) dismissed CANUSWA ACCOUNTING & TAX SERVICES INC.
(
CANUSWA
) as the Companys independent registered public accounting
firm. The decision to dismiss CANUSWA was approved by the Companys sole
director.
The principal accountants reports of CANUSWA on the financial
statements of the Company as of and for the fiscal years ended June 30, 2016 and
2015 did not contain any adverse opinion or disclaimer of opinion and was not
qualified or modified as to uncertainty, audit scope or accounting
principles.
During the Companys two most recent fiscal years and the
subsequent interim period through January 12, 2017, there were no disagreements
with CANUSWA on any matter of accounting principles or practices, financial
statement disclosure, or auditing scope or procedure, which disagreement(s) if
not resolved to CANUSWAs satisfaction would have caused it to make reference to
the subject matter of the disagreement(s) in connection with its report. During
the Companys two most recent fiscal years and the subsequent interim period
through January 12, 2017, there were no reportable events of the type described
in Item 304(a)(1)(v) of Regulation S-K.
The Company provided CANUSWA with a copy of the foregoing
disclosure and requested CANUSWA to furnish the Company with a letter addressed
to the Securities and Exchange Commission stating whether it agrees with the
statements made therein. A copy of such letter, dated January 12, 2017,
furnished by CANUSWA, is filed as Exhibit 16.1 to this Form 8-K.
On January 12, 2017, the Companys sole director approved the
engagement of Centurion ZD CPA Limited (
Centurion
) as the Companys new
independent registered public accounting firm.
During the Companys two most recent fiscal years and the
subsequent interim period through January 12, 2017, neither the Company nor
anyone on its behalf consulted with Centurion regarding (i) the application of
accounting principles to a specified transaction, either completed or proposed;
the type of audit opinion that might be rendered on the Company's financial
statements, and neither a written report nor oral advice was provided that
Centurion concluded was an important factor considered by the Company in
reaching a decision as to the accounting, auditing or financial reporting issue;
or (ii) any matter that was either the subject of a disagreement (as defined in
Item 304(a)(1)(iv) of Regulation S-K and its related instructions) or a
reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).
Item 9.01.
|
Financial Statements and
Exhibits.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: January 12, 2017
CHINA HEALTH INDUSTRIES
HOLDINGS, INC.
|
|
|
By:
|
/s/ Xin Sun
|
Name:
|
Xin Sun
|
Title:
|
Chief Executive Officer and Chief Financial
Officer
|
China Health Industries (QB) (USOTC:CHHE)
Historical Stock Chart
From Mar 2024 to Apr 2024
China Health Industries (QB) (USOTC:CHHE)
Historical Stock Chart
From Apr 2023 to Apr 2024